Skip to content

Gross margin at other companies

Medtronic logo
MedtronicMDT
65%-0.3pp
LivaNova logo
LivaNovaLIVN
67.5%-0.5pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
62.3%+1.1pp
Inspire Medical Systems logo
Inspire Medical SystemsINSP
85.8%+1.1pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
86%-0.2pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
91.5%-0.6pp

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Gross profit$18.0M+4.1%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Calculated from Neuropace, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s gross margin?
Neuropace, Inc. (NPCE) reported gross margin of 78.3% in Q1 2026.
How has Neuropace, Inc.'s gross margin changed year-over-year?
Neuropace, Inc.'s gross margin increased by 4.6% year-over-year, from 74.8% to 78.3%.
What is the long-term trend for Neuropace, Inc.'s gross margin?
Over 5 years (2020 to 2025), Neuropace, Inc.'s gross margin has grown at a 1.0% compound annual growth rate (CAGR), from 73.6% to 77.2%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.